What's breaking now, across thousands of outlets.
LONDON — Sandoz is betting big on its newly formed biosimilar unit, as it reveals plans to grow its pipeline there by more than sevenfold and also invests $300 million in a new biosimilar manufacturing site. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to the CDC.
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news
CAR-T therapy has revolutionized blood cancer treatment, particularly in multiple myeloma. But an ongoing concern remains: If patients’ cancers progress after receiving CAR-T, what other options do…
Kenya is mourning the loss of Maureen Nyadida-Lukoye, the beloved wife of renowned psychiatrist Prof. Lukoye W’Atwoli, who passed away on Tuesday, September 8, 2026, following a courageous battle with…
Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.
A study shows that tobacco smoking could lead to 40% higher risk of infertility in women, and lead to semen abnormalities and sexual dysfunction in men
